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Abstract
Background: There is evidence to suggest that decision aids improve a number of patient outcomes. However,
little is known about the progression of research effort in this area over time. This literature review examined the
volume of research published in 2000, 2007 and 2014 which tested the effectiveness of decision aids in improving
cancer patient outcomes, coded by cancer site and decision type being targeted. These numbers were compared
with the volume of research examining the effectiveness of strategies to increase the adoption of decision aids by
healthcare providers.
Methods: A literature review of intervention studies was undertaken. Medline, Embase, PsychInfo and Cochrane
Database of Systematic Reviews were searched. The search was limited to human studies published in English,
French, or German. Abstracts were assessed against eligibility criteria by one reviewer and a random sample of
20 % checked by a second. Eligible intervention studies in the three time periods were categorised by: i) whether
they tested the effectiveness of decision aids, coded by cancer site and decision type, and ii) whether they tested
strategies to increase healthcare provider adoption of decision aids.
Results: Over the three time points assessed, increasing research effort has been directed towards testing the
effectiveness of decision aids in improving patient outcomes (p < 0.0001). The number of studies on decision aids
for cancer screening or prevention increased statistically significantly (p < 0.0001) whereas the number of studies on
cancer treatment did not (p = 1.00). The majority of studies examined the effectiveness of decision aids for prostate
(n = 10), breast (n = 9) or colon cancer (n = 7). Only two studies assessed the effectiveness of implementation
strategies to increase healthcare provider adoption of decision aids.
Conclusions: While the number of studies testing the effectiveness of decision aids has increased, the majority of
research has focused on screening and prevention decision aids for only a few cancer sites. This neglects a number
of cancer populations, as well as other areas of cancer care such as treatment decisions. Also, given the apparent
effectiveness of decision aids, more effort needs to be made to implement this evidence into meaningful benefits
for patients.
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Background
Patients as key players in their own healthcare
Over the last two decades cancer care has evolved from
a paternalistic, clinician-centred model to a patient-
centred model [1, 2]. Patient-centred care places great
emphasis on involving patients in their own healthcare
[3, 4]. Clinical decision making is now largely viewed as
a collaborative process in which the clinician, the patient
(and their support persons) choose healthcare options
together, based on the patient’s informed preferences
[5, 6]. Involving patients in their healthcare decisions
is associated with improved patient outcomes, includ-
ing decreases in patient unmet information needs and
anxiety and increases in patients’ satisfaction with the
consultation [7, 8]. Shared decision making can im-
prove patients’ quality of life [9–12].
Preference-sensitive healthcare decisions are challenging
Patients’ willingness to become involved in decisions
may be hampered by difficulties in choosing between the
various healthcare options available to them [13, 14].
This is especially true for “preference-sensitive” deci-
sions, where there is little or no difference in the med-
ical effectiveness of the available healthcare options. In
these instances the final decision involves weighing up
the costs and benefits of the different options according
to the values and preferences of the patient [3, 15]. With
an increasing variety of treatment and care options,
more and more cancer prevention, screening and treat-
ment decisions are becoming “preference sensitive.” For
example, early-stage breast cancer patients and their cli-
nicians may have a number of different treatment op-
tions to choose from, including surgery, cytotoxic or
endocrine therapy [16]. Some patients may have the op-
tion to decide whether they receive chemotherapy before
surgery (neoadjuvant) or after surgery (adjuvant). Each of
these treatments shows similar medical effectiveness for
these patients but holds various side effects and impacts
that may be valued differently by different patients [17].
Decision aids to help patients make difficult healthcare
decisions
To assist patients in making these difficult decisions,
healthcare providers have been encouraged to use pa-
tient decision aids. Decision aids are interventions which
provide patients with specific information on their avail-
able options and guide patients towards choosing the
option that aligns with their values. They intend to en-
courage patients to become more involved in the deci-
sion making process [18, 19]. Decision aids can be
delivered in various formats, such as face-to-face, as
written booklets or web-based tools [20]. They cover a
variety of healthcare options, including cancer screening,
prevention and treatment [21].
There is evidence for the effectiveness of decision aids
Numerous reviews have provided considerable evidence
of the effectiveness of decision aids in improving patient
outcomes [22–25]. The first Cochrane review on the ef-
fectiveness of decision aids was published in 2001, and
concluded that decision aids improve knowledge, reduce
decisional conflict, and stimulate patients to be more ac-
tive in decision making [26]. Updated versions of this re-
view were published in 2003, 2009, 2011 and 2014,
which all supported the original findings [20, 27–29]. To
date, over 100 Randomized Controlled Trials (RCTs)
exist that demonstrate that decision aids are effective in
improving patient outcomes. Despite the evidence for
the effectiveness of decision aids, they are not commonly
used in practice [30]. Previous research has identified
barriers and enablers which preclude the implementa-
tion of decision aids [31–33]. Little is known about
whether the focus of research on the effectiveness of de-
cision aids has changed over time and whether this evi-
dence has translated into the development and testing of
strategies to implement decision aids. Once the effective-
ness of decision aids in a certain area has been established,
research should move from testing the effectiveness of
these interventions to testing the effectiveness of imple-
menting decision aids into routine care.
Research output as measure of research effort
Examining the volume of peer-reviewed research output
using bibliometric methods can be used as a proxy indica-
tor of scientific productivity [34–37]. As a result, assessing
the volume of research output can provide an indication
of the focus of research effort and where future research is
needed most. To date, there has been no time sampling of
the volume of research examining the effectiveness of de-
cision aids compared to the volume examining the effect-
iveness of strategies to increase their adoption by
healthcare providers. We aimed to give an indication of
the focus of research efforts, in order to provide an indica-
tion of where future research is required.
Aims
The aim of this review was to provide a snapshot of
where research effort focusing on cancer-related deci-
sion aids has been directed to over the last 15 years.
We examined changes in the volume of research that
examined the effectiveness of cancer-related decision
aids, across three time points. We also categorised
eligible articles by cancer type and decision being tar-
geted. Finally, we compared the number of studies
that assessed the effectiveness of cancer-related deci-
sion aids to the number of studies that assessed strat-
egies to increase the adoption of decision aids by
healthcare providers.
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Methods
Literature search
The electronic databases Medline, Embase, PsychInfo
and Cochrane Database of Systematic Reviews were
searched using the OVID platform. We selected these
databases due to their focus on biomedicine and health
publications in scholarly journals. The search strategy
included three categories of search terms and subject
headings: cancer, decision making/decision aids and
patient participation. We adapted the search strategy
to the requirements of each individual database. The
full search strategy for each database is available in
Additional file 1. Searches were restricted to English,
French and German language publications and human
studies. Although most scientific research is published in
English, the importance of non-English studies is hard to
predict [38, 39]. English, French and German belong to
the most common alternative languages used in scientific
research [40–42]. Studies published in French or German
were included in this review to reduce the likelihood of
English language bias. Reference lists of systematic reviews
on the effectiveness of decision aids were also searched to
ensure that all relevant studies were included in this
paper. Where feasible and applicable the PRISMA guide-
lines were followed [43].
Inclusion and exclusion criteria
Studies were included if they were intervention studies
which examined either: the effectiveness of decision aids
on patient outcomes or the effectiveness of strategies to
increase provider adoption of patient decision aids. Eli-
gible papers were those published in any country in
2000, 2007 or 2014. These time periods were chosen
prospectively as the patient-centred care model gained
popularity after the influential report ‘Ensuring Quality
Cancer Care’ released by the US National Cancer Board
published in 1999, advocating for patient-centred care
[2]. Awareness of the patient-centred model was further
heightened by the 2001 Institute of Medicine report
‘Crossing the Quality Chasm’ [1]. We excluded case
studies, commentaries, conference abstracts, proposed
studies, protocol papers and editorials.
Definitions
We based our definition of patient decision aids on that
proposed by the International Patient Decision Aid Stan-
dards (IPDAS) Collaboration [44–46]. IPDAS aims to
improve the quality and effectiveness of patient decision
aids by establishing standards for improving their
content, development, implementation, and evaluation
[18, 19, 47]. Decision aids were defined as interventions
which help patients to participate in making deliberated
choices among healthcare options. They explicitly
state the decision to be made and provide specific,
evidence-based information on the available health-
care options as well as information on the possible
risks and benefits of each option. Decision aids aim
to help patients to clarify and communicate the value
they associate with each option [20, 46]. Strategies to
increase healthcare provider adoption of decision aids
were defined as any actions taken in order to increase
provider usage of decision aids in clinical practice.
Implementation strategies were coded as such if they
were targeted at the healthcare provider, and/or if
they were targeted at the healthcare system.
Paper coding
After removing the duplicate results, abstracts were
screened according to the eligibility criteria by one re-
viewer (AH). They were rejected if the reviewer deter-
mined from the title and abstract that the study did not
meet the inclusion criteria. Full text copies of the
remaining publications were retrieved and further
assessed against the eligibility criteria by the same re-
viewer (AH). A random sample of 20 % of full text stud-
ies identified as eligible were checked for relevance and
double-coded by a second reviewer (EM). Eligible stud-
ies in the three time periods were categorised by
whether they tested: i) the effectiveness of decision aids
in improving cancer patients’ outcomes, or ii) the adop-
tion of decision aids by healthcare providers. Studies
testing the effectiveness of decision aids were also coded
by cancer type of the study sample. The type of decision
being targeted was coded as either screening/prevention
or treatment. Screening decisions aids include those
which assist patients to make a decision about whether
they want to undergo cancer screening, such as mam-
mography and colonoscopy. Cancer prevention decision
aids include those which assist patients to make a deci-
sion about whether they will undergo a procedure to
lower the risk of getting cancer, such as prophylactic
mastectomy or immunisation. Cancer treatment decision
aids include those designed to help patients choose be-
tween different cancer treatments.
Analysis
One way trend tests were performed to examine the
changes in the proportions of studies on the effective-
ness of decision aids as well as on screening or preven-
tion and treatment decision aids separately across time.
Analyses were programmed using Stata v13.0 (StataCorp
Ltd, College Station, TX).
Results
Search results
As shown in Fig. 1, a total of 2,690 citations were re-
trieved using the search strategy. Of these, 35 full-text
studies met the eligibility criteria and were included in
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this review. Double coding of 20 % of all full-text articles
resulted in 100 % agreement between the reviewers
(Kappa = 1.000). A list of included citations is provided
in Additional file 2.
Studies reporting on the effectiveness of decision aids
Of the included studies, 33 tested the effectiveness of de-
cision aids in improving cancer patient outcomes. The
number of studies examining the effectiveness of deci-
sion aids increased significantly across the three time
points (p < 0.0001), from 8 studies in 2000 (22.8 %), to
10 studies in 2007 (28.5 %) and 15 studies in 2014
(42.8 %). As shown in Fig. 2, the majority of these papers
focused on decision aids for cancer screening and pre-
vention (n = 26), compared to those focused on treat-
ment (n = 7). Across the three time points assessed, the
number of studies focusing on cancer screening and pre-
vention decision aids increased significantly (p < 0.0001),
while the number focused on cancer treatment did not
(p = 1.00, Fig. 2). Decision aids were found for breast,
prostate, colon, lung, pancreatic, skin, ovarian and cer-
vical cancer. The majority of studies focused on prostate
(n = 10), breast (n = 9) and colon cancer (n = 7). Two
studies focused on more than one cancer type, including
breast, ovarian, cervical and colon cancer (Fig. 3).
Studies reporting on strategies to implement decision
aids
Only the two remaining studies, published in 2000 and
2007, assessed the effectiveness of strategies to increase
the implementation of decision aids into clinical prac-
tice. Due to the low number of these studies, a statistical
comparison was not performed. The number of studies
testing the effectiveness of decision aids vs the number
of studies examining implementation strategies are re-
ported in Fig. 4.
Discussion
Research priorities by relative volume of intervention
studies
We examined the progression of research volume which
tested the effectiveness of decision aids by cancer site and
decision type being targeted, across three time points.
Also, we compared these numbers with the volume of re-
search testing the effectiveness of strategies to increase the
adoption of decision aids by healthcare providers. Our
data suggests that an increase in research effort has been
directed towards assessing the effectiveness of decision
aids for cancer screening and prevention. The majority of
studies focused on prostate, breast and colon cancer. Only
two studies examined the effectiveness of strategies to
Fig. 1 Flow chart of search strategy and study selection, according to the PRISMA guidelines [43]
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increase provider adoption of decision aids, despite evi-
dence illustrating the benefit of decision aids’ for some pa-
tient outcomes [20, 25].
Lack of research on the effectiveness of decision aids for
cancer treatment
Although decision aids are available for a number of
healthcare decisions, research has been increasingly
focusing on screening and prevention decisions as
opposed to treatment decisions. One reason for the
larger volume of screening and prevention decision
aids may be that these interventions are aimed at
healthy people, rather than a vulnerable patient
group. This can facilitate the research process, for
example by easier access to large sample sizes and
by the facilitation of the ethical review process. De-
veloping and testing decision aids on treatment op-
tions needs considerable clinical input, which relies
on strong collaborations between researchers and cli-
nicians [48, 49]. For example, clinicians may vary in
their preferences for different treatment options
based on their clinical experience [50]. If clinicians
disagree in the content of a decision aid, the devel-
opment of such decision aids might be hindered [32, 51].
However, treatment decisions can be very distressing
for patients [13]. Also, as the number of treatment
options available to patients has been increasing, par-
ticularly in relation to “preference sensitive” treat-
ments, opportunities arise to develop and test
decision aids for cancer treatment decisions.
Fig. 2 Numbers of studies on the effectiveness of decision aids by decision type being targeted
Fig. 3 Numbers of studies on the effectiveness of decision aids by cancer site
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Narrow research focus on decision aids for only a few
cancer types
Over the last 15 years, increasing research effort has been
directed towards examining the effectiveness of decision
aids on prostate, breast and colon cancer. This may seem
understandable as according to the latest GLOBOCAN
statistics these are amongst the most prevalent cancer
types worldwide [52]. Screening recommendations for
breast, colon and prostate cancer have been established for
decades which could further explain the increased research
volume focused on these sites [53]. However, research with
other cancer types where decision aids could be beneficial
seems to be sparse. For instance, there are guideline rec-
ommendations for cervical cancer screening, prevention
and treatment, which could motivate decision aid research
in this area [54, 55]. But a lack of such research across
these three time periods has been shown. Also, lung cancer
has high incidence and burden, but little research exists
about decision aids for lung cancer screening, prevention
and treatment [20, 25]. This might be because there are no
nationally standardised screening programmes for lung
cancer in many countries as there are for other types of
cancer, such as breast or colon [53, 56, 57]. However, many
lung cancer patients are faced with difficult healthcare de-
cisions, such as a choice between different treatment mo-
dalities. Some of these require the patient to decide
between a slightly higher chance of longer survival or
fewer treatment related side-effects [58, 59]. Thus there is
a need for effective decision aids for cancer populations
other than prostate, breast or colon.
Lack of research effort towards testing effective
implementation strategies
This review has shown that the research volume on de-
cision aids for cancer screening and prevention has
increased over the three time points assessed. Given that
decision aids are not commonly used in practice [30], it
may be expected that we should have started to see the
testing of strategies to implement decision aids that have
been shown to be effective. However, we found only two
studies on the effectiveness of implementation strategies
across the three time periods assessed. The little attempt
to translate evidence into meaningful benefits for
patients may result from various factors, such as meth-
odological difficulties of carrying out well-controlled im-
plementation trials; perception that optimal care is
already being delivered; difficulties of addressing further
barriers to the adoption of decision aids in practice; and
potential further questions to be answered by ongoing
research on the effectiveness of decision aids. These fac-
tors are discussed below.
Methodological difficulties of carrying out implementation
trials
Implementation of decision aids may involve changes in
processes of care. This necessitates system-orientated
change, which is not always amenable to the “gold-
standard” RCT intervention design. Decision aids are
complex interventions in a complex field of social inter-
actions. They address various influences on behaviour.
Attention should be paid to this complexity and to the
context of implementation [24, 60]. It has been argued
that RCTs are not suitable for taking into account all
relevant contextual factors in which complex interven-
tions are delivered and received [61]. The randomization
and blinding required by RCTs cannot always accommo-
date the complexity and flexibility needed to test these
interventions on a system level [62, 63]. According to
the Medical Research Council's guidance for evaluating
complex interventions, a range of alternate study designs
Fig. 4 Number of studies on the effectiveness of decision aids compared to the number of studies on implementation strategies
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should be considered, including Stepped Wedge or
Multiple Baseline Designs [64, 65]. Future attempts to
test implementation strategies should consider these de-
signs. As planning and conducting such complex trials
takes an extended period of time it may be that much of
the implementation research is still being carried out
[66]. It is possible that we see a surge in such studies in
the near future.
Perception that optimal care is already being delivered
There may be an assumption that evidence-based strat-
egies are already being used in practice. For example,
O’Brien and colleagues reported that some clinicians
have high confidence in their own communication skills
and believe that patients understand the information
they have conveyed [31]. Clinicians in this study have in-
dicated that decision aids’ effects on the decision making
process are not compelling enough to change their prac-
tice. Consequently, some have argued that there is no
need to conduct research to implement decision aids
into routine care [31]. However, given the increasing
range and availability of prevention, screening and treat-
ment options, healthcare decisions have become increas-
ingly difficult. Especially in clinical situations where
there is low or conflicting evidence on the medical ef-
fectiveness of the available healthcare options it is cru-
cial to involve patients’ preferences in the decision
making process.
Further barriers to the adoption of decision aids in practice
Findings of previous research indicate that clinicians
identify numerous barriers that affect their ability to im-
plement patient decision aids [31–33, 67]. Such barriers
include: concerns about how comprehensive and current
the content of decision aids is, lack of awareness of
existing decision aids, time constraints, and concerns
about how to integrate decision aids into clinicians’
workflow [32, 68]. Designing implementation strategies
to overcome these barriers is challenging. There is little
evidence that passive dissemination through strategies
such as guidelines is effective [69]. Implementation strat-
egies need to actively target healthcare providers, pa-
tients or both [66]. They should be tailored to the
specific setting avoiding “one-fits-all-solutions”. Instead
of controlling for confounding variables, implementation
attempts need to investigate these variables in order to
better understand the long-term implementation of deci-
sion aids [70]. Practice-based research within the real
world setting of daily cancer care needs to be conducted
[71]. Researchers should focus on illuminating processes,
rather than “package” and use the strengths of collabora-
tive research across various contexts in order to system-
atically study the impact of the individual settings [70].
Open questions regarding the effectiveness of decision aids
Although there is a large body of evidence demonstrat-
ing that decision aids are effective in improving a range
of patient outcomes, open questions remain in regards
to the stated effectiveness. For example, further studies
are required which explore the “active ingredients” of
decision aids and clinically relevant outcomes apart from
the ones already assessed [24]. Greater understanding of
the mechanisms of action of decision aids and further
evidence for their clinical impact may increase their ac-
ceptability in clinical practice and motivate more at-
tempts to design and evaluate implementation strategies.
Further open questions remain in regards to the “orien-
tation” and “insight” phase of implementing decision
aids into practice. Consequently, we need further in-
depth investigation of clinicians’ understanding and
opinion on decision aids before we ask them to imple-
ment these tools [23, 51, 72, 73]. However, as the body
of work on the effectiveness of decision aids has been
growing, we hope that the number of intervention stud-
ies which test implementation strategies will develop
accordingly.
Limitations
The results of this study should be considered in light of
several limitations. First, only three years of publication
were included in this study. It is possible that the trends
in research output differ in the years which were not
assessed. In addition, due to the low numbers of eligible
studies, it was not possible to compare statistically the
trends in effectiveness and implementation trials over
time. This limits the strength of our conclusions about
the relative increase in effectiveness compared with im-
plementation trials. However, the inclusion of these
three time points provides an indication of research ef-
fort over the past 15 years. Grey literature such as policy
documents and dissertations were not included as they
do not meet the standards associated with peer-reviewed
publications. It is possible that the exclusion of such re-
search has biased the results due to the file drawer prob-
lem, whereby studies showing null (or negative) findings
tend not to be published. The exclusion of conference
abstracts may have led to underestimating the number
of implementation studies currently underway.
Conclusions
Although multiple Cochrane reviews provide evidence
that decision aids are effective in improving a range of
patient outcomes, our review suggests that research test-
ing the effectiveness of decision aids has increased over
the three time points assessed. Research effort in this
area has focused predominantly on screening and pre-
vention decisions in only a few cancer sites. This ne-
glects a number of cancer populations, as well as other
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areas of cancer care such as treatment decisions. Further,
once the effectiveness of certain decision aids is estab-
lished, strategies to increase their adoption by healthcare
providers need to be designed and tested. Such research
will help to ensure that the benefits of decision aids
reach the intended patient populations.
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